Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracoronary brachytherapy.

Phong Nguyen-Ho1, Grzegorz L Kaluza, Pawel T Zymek

  • 1The Methodist DeBakey Heart Center and Baylor College of Medicine, Houston, Texas, USA.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|July 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of IVUS Guidance on Clinical and Procedural Outcomes in Intracoronary Brachytherapy.

JACC. Advances·2026
Same author

Sex-Based Differences in Long-Term Outcomes Following Intravascular Brachytherapy for In-Stent Restenosis.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Intravascular brachytherapy vs. drug-coated balloons for in-stent restenosis in patients with diabetes.

Frontiers in cardiovascular medicine·2026
Same author

Impact of diabetes in long-term outcomes following intravascular brachytherapy for in-stent restenosis.

Cardiovascular revascularization medicine : including molecular interventions·2025
Same author

Intravascular Brachytherapy for In-Stent Restenosis in Patients With Chronic Kidney Disease.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same author

Lesion Preparation Before Coronary Intravascular Brachytherapy: A Comparison of Plain Balloon Versus Cutting/Scoring Balloon Angioplasty.

Journal of the Society for Cardiovascular Angiography & Interventions·2025

Intracoronary brachytherapy effectively prevents recurrent in-stent restenosis in patients needing repeat interventions. This radiation therapy is not recommended for new lesions and is contraindicated in patients unable to adhere to long-term antiplatelet therapy.

Area of Science:

  • Interventional Cardiology
  • Radiation Oncology
  • Medical Device Technology

Background:

  • In-stent restenosis increases the need for repeat cardiovascular interventions.
  • Intracoronary brachytherapy is an established treatment for preventing restenosis within previously stented arteries.

Purpose of the Study:

  • To review the indications and contraindications for intracoronary brachytherapy.
  • To discuss current FDA-approved intravascular brachytherapy systems and their application.

Main Methods:

  • Review of current clinical evidence and FDA labeling for intracoronary brachytherapy.
  • Analysis of treatment protocols, including antiplatelet therapy duration.

Main Results:

  • Three FDA-approved systems exist: one gamma (Cordis) and two beta (Novoste, Guidant).

Related Experiment Videos

  • Brachytherapy is not indicated for de novo coronary lesions.
  • Prolonged dual antiplatelet therapy (6-12 months) is mandatory, making it contraindicated for non-compliant patients.

    • Conclusions:

    • Intracoronary brachytherapy is a valuable tool for managing in-stent restenosis.
    • Careful patient selection and adherence to antiplatelet regimens are critical for successful outcomes.
    • Avoidance of new stent placement is preferred when possible to minimize antiplatelet duration.